Inion Oyj - Financial Calendar

Notice of Preliminary Results for Year Ended 31 December 2006

Inion Oy                                     

         Notice of Preliminary Results for Year Ended 31 December 2006          
                                and Presentation                                
                              of Strategic Review                               

Tampere, Finland and Takeley, UK. 13 March 2007…Inion [LSE: IIN.L], a company   
focused on the development of novel biodegradable medical implant, will be      
announcing its preliminary results for the year ended 31 December 2006 on       
Tuesday, 20 March 2007. The Company will also be presenting its full year       
results and the conclusions of its Strategic Review at a meeting for analysts to
be held at 09.30hrs on 20 March 2007 at the offices of Piper Jaffray Ltd, One   
South Place, London EC2M 2RB.                                                   

                                     -Ends-                                     

For further information please contact:                                         

--------------------------------------------------------------------------------
| Inion Oy	                                 | Tel: +44 1279 874 222            |
| Dr Auvo Kaikkonen, Chief Executive        | Tel: +44 358 3 230 6600          |
| Officer                                   |                                  |
| Julien Cotta, Chief Financial Officer     |                                  |
| 	                                         |                                  |
--------------------------------------------------------------------------------
| Citigate Dewe Rogerson                    | Tel: +44 207 638 9571            |
| Mark Swallow / David Dible / Helena       |                                  |
| Galilee                                   |                                  |
--------------------------------------------------------------------------------

About Inion (www.inion.com)                                                     
Inion Oy is a Finnish company that specializes in the development of            
biodegradable medical implants.                                                 

The Inion core expertise and technology lies in the design and manufacture of   
innovative biodegradable plates, screws, pins and membranes that are used to    
enhance the healing of skeletal injuries (bone and soft tissue), such as those  
caused by trauma or by reconstructive surgery. Inion implants are made from its 
proprietary Inion Optima™ family of biomaterials, with properties tailored for  
specific surgical applications, in terms of strength, flexibility and rate of   
degradation.                                                                    
                                                                                
Inion has developed and launched products in five strategic business areas -    
cranio-maxillofacial surgery, orthopaedic trauma, sports medicine, dental       
surgery and most recently in the spinal implant area - in nearly 50 countries   
worldwide.                                                                      

Inion was incorporated in early 2000 by an international team of experts in     
biodegradable materials and their clinical applications, and listed on the      
Official List of the UK Listing Authority in December 2004. The Company's has   
operations in the UK, R&D and production facilities in Tampere, Finland, and a  
US office in Oklahoma City, OK.                                                 


This announcement includes "forward-looking statements" which include all       
statements other than statements of historical facts, including, without        
limitation, those regarding the Group's financial position, business strategy,  
plans and objectives of management for future operations (including development 
plans and objectives relating to the Group's products), and any statements      
preceded by, followed by or that include forward-looking terminology such as the
words "targets", "believes", "estimates", "expects", "aims", "intends", "will", 
"can", "may", "anticipates", "would", "should", "could" or similar expressions  
or the negative thereof. Such forward-looking statements involve known and      
unknown risks, uncertainties and other important factors beyond the Group's     
control that could cause the actual results, performance or achievements of the 
Group to be materially different from future results, performance or            
achievements expressed or implied by such forward-looking statements. Such      
forward-looking statements are based on numerous assumptions regarding the      
Group's present and future business strategies and the environment in which the 
Group will operate in the future. Among the important factors that could cause  
the Group's actual results, performance or achievements to differ materially    
from those in forward-looking statements include those relating to Inion's      
funding requirements, regulatory approvals, reliance on third parties,          
intellectual property, key personnel and other factors. These forward-looking   
statements speak only as at the date of this announcement. The Group expressly  
disclaims any obligation or undertaking to disseminate any updates or revisions 
to any forward-looking statements contained in this announcement to reflect any 
change in the Group's expectations with regard thereto or any change in events, 
conditions or circumstances on which any such statements are based. As a result 
of these factors, prospective investors are cautioned not to rely on any        
forward-looking statement.